TG THERAPEUTICS, INC.
TGTXUS売上高
$616M
百万USD
営業利益
$123M
百万USD
純利益
$447M
百万USD
ROE
69.0%
最新FY
EPS
$2.77
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | - | - |
| FY2021 | Q2 | - | - | - |
| FY2021 | Q3 | - | - | - |
| FY2021 | FY | - | - | - |
| FY2022 | Q1 | - | - | $-0.51 |
| FY2022 | Q2 | - | - | $-0.30 |
| FY2022 | Q3 | - | - | $-0.26 |
| FY2022 | FY | - | - | $-1.46 |
| FY2023 | Q1 | $8M | - | $-0.28 |
| FY2023 | Q2 | $16M | - | $-0.34 |
| FY2023 | Q3 | $166M | $114M | $0.73 |
| FY2023 | FY | $234M | $13M | $0.09 |
| FY2024 | Q1 | $63M | $-11M | - |
| FY2024 | Q2 | $73M | $7M | $0.04 |
| FY2024 | Q3 | $84M | $4M | $0.02 |
| FY2024 | FY | $329M | $23M | $0.15 |
| FY2025 | Q1 | $121M | $5M | $0.03 |
| FY2025 | Q2 | $141M | $28M | $0.17 |
| FY2025 | Q3 | $162M | $391M | $2.43 |
| FY2025 | FY | $616M | $447M | $2.77 |
| FY2026 | Q1 | $205M | $20M | $0.12 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | - | $234M | $329M | $616M |
| 営業利益 | $-79M | $-119M | $-174M | $-169M | $-274M | $-345M | $-193M | $21M | $42M | $123M |
| 純利益 | - | - | - | - | - | - | - | $13M | $23M | $447M |
| 総資産 | $55M | $97M | $84M | $163M | $626M | $380M | $194M | $330M | $578M | $1.1B |
| 純資産 | $36M | $67M | $24M | $39M | $519M | $237M | $59M | - | - | - |
| 自己資本 | - | - | - | - | - | - | - | $161M | $222M | $648M |
| 営業CF | - | - | - | $-133M | $-215M | $-296M | $-176M | $-31M | $-41M | $-25M |
| EPS | - | - | - | - | - | - | $-1.46 | $0.09 | $0.15 | $2.77 |
| BPS | - | - | - | - | - | - | - | $1.04 | $1.42 | $4.06 |
| ROE | - | - | - | - | - | - | - | 7.9% | 10.5% | 69.0% |